Gene Therapy
Base Excision Repair
In-vitro Mutagenesis
Nucleotide Excision Repair
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Apr 29, 2026
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Alain Fischer1
1Imagine Institute, Hôpital Necker-Enfants Malades, Paris 75015, France, and at the Collège de France, Paris.
No abstract available in PubMed .
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023